Verition Fund Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-98,446
Closed -$1.13M – 3469
2024
Q3
$1.13M Sell
98,446
-260,739
-73% -$2.97M 0.01% 1801
2024
Q2
$4.05M Hold
359,185
– – 0.02% 848
2024
Q1
$3.99M Hold
359,185
– – 0.03% 812
2023
Q4
$3.94M Buy
359,185
+195,000
+119% +$2.12M 0.03% 534
2023
Q3
$1.77M Hold
164,185
– – 0.02% 839
2023
Q2
$1.75M Hold
164,185
– – 0.02% 731
2023
Q1
$1.72M Hold
164,185
– – 0.02% 746
2022
Q4
$1.68M Hold
164,185
– – 0.03% 691
2022
Q3
$1.64M Buy
+164,185
New +$1.65M 0.02% 1049

Other funds holding RENE

Verition Fund Management's RENE Position: Q4 2024 in Review

Verition Fund Management sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 98,446 shares — an estimated $1.13M sold.

Verition Fund Management first reported a position in RENE in Q3 2022 and held it in 9 quarters. The position peaked at $4.05M in Q2 2024. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • Verition Fund Management reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 98,446 Cartesian Growth Corp II shares in Q4 2024, an estimated $1.13M.
  • Verition Fund Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 9 quarters.
  • Verition Fund Management's Cartesian Growth Corp II position peaked at $4.05M in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.